Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1

…, B Dréno, MH Tessier, E Rankin… - … journal of cancer, 1999 - Wiley Online Library
Thirty‐nine tumor‐bearing patients with metastatic melanoma were treated with 3 subcutaneous
injections of the MAGE‐3.A1 peptide at monthly intervals. No significant toxicity was …

[HTML][HTML] Prophylactic cranial irradiation in extensive small-cell lung cancer

…, C Faivre-Finn, G Kramer, E Rankin… - … England Journal of …, 2007 - Mass Medical Soc
Background We conducted a randomized trial of prophylactic cranial irradiation in patients
with extensive small-cell lung cancer who had had a response to chemotherapy. Methods …

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European …

…, J Buesa, P Casali, D Spooner, E Rankin - Journal of Clinical …, 1995 - ascopubs.org
PURPOSE The aim of this trial was to compare the activity and toxicity of single-agent
doxorubicin with that of two multidrug regimens in the treatment of patients with adult advanced …

[PDF][PDF] Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study

…, M Atkins, A Buzaid, D Skarlos, EM Rankin - Journal of clinical …, 2004 - researchgate.net
Purpose Temozolomide is a well-tolerated oral alkylating agent with activity in the CNS. A
multicenter, open-label, phase II study was conducted to assess the safety and efficacy of …

[HTML][HTML] Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms—results of …

…, C Faivre-Finn, GWPM Kramer, EM Rankin… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Purpose Prophylactic cranial irradiation (PCI) in patients with extensive-disease small-cell
lung cancer (ED-SCLC) leads to significantly fewer symptomatic brain metastases and …

Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in …

AM Kaufmann, PL Stern, EM Rankin, H Sommer… - Clinical Cancer …, 2002 - AACR
Purpose : Cervical cancer, the second most common malignancy in women worldwide, is
almost invariably associated with infection by human papillomavirus (HPV). HPV-16 or -18 is …

The effectiveness of clinical education models for undergraduate nursing programs: A systematic review

R Jayasekara, C Smith, C Hall, E Rankin… - Nurse education in …, 2018 - Elsevier
Clinical nurse education is a major part of all undergraduate programs preparing nurses for
competent professional practice. While research mostly evaluated specific clinical education …

[HTML][HTML] Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers

…, WJ Petty, JB Chick, E Rankin… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Purpose Cigarette smoking induces CYP1A1/1A2 and is hypothesized to alter erlotinib
pharmacokinetics. This study aimed to determine the maximum tolerated dose (MTD) of erlotinib …

[PDF][PDF] Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With Autologous GM-CSF–Transduced Tumor Cells in Metastatic Melanoma Patients

…, W Mooi, MPW Gallee, EM Rankin… - Journal of clinical …, 2005 - researchgate.net
Purpose To determine the feasibility, toxicity, and immunologic effects of vaccination with
autologous tumor cells retrovirally transduced with the GM-CSF gene, we performed a …

A mathematical model of the development of drug resistant to cancer chemotherapy

BG Birkhead, EM Rankin, S Gallivan, L Dones… - European Journal of …, 1987 - Elsevier
A mathematical model incorporating descriptions of tumour growth kinetics and the effects
of cytotoxic chemotherapy on established tumours, is presented. It is shown how models of …